These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16898617)

  • 1. [Effect of polycarbophil Ca on IBS].
    Mine T
    Nihon Rinsho; 2006 Aug; 64(8):1483-6. PubMed ID: 16898617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarbophil.
    Chiba T; Sato K; Toya Y; Endo K; Abiko Y; Kasugai S; Saito S; Oana S; Kudara N; Endo M; Suzuki K
    Hepatogastroenterology; 2011; 58(110-111):1527-30. PubMed ID: 21940313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
    Chiba T; Kudara N; Sato M; Chishima R; Abiko Y; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2005; 52(65):1416-20. PubMed ID: 16201086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium polycarbophil compared with placebo in irritable bowel syndrome.
    Toskes PP; Connery KL; Ritchey TW
    Aliment Pharmacol Ther; 1993 Feb; 7(1):87-92. PubMed ID: 8439642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)].
    Iwanaga Y
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):185-90. PubMed ID: 11915521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium polycarbophil (Mitrolan).
    Med Lett Drugs Ther; 1981 May; 23(11):52. PubMed ID: 7015097
    [No Abstract]   [Full Text] [Related]  

  • 7. Laxative and anti-diarrheal activity of polycarbophil in mice and rats.
    Saito T; Mizutani F; Iwanaga Y; Morikawa K; Kato H
    Jpn J Pharmacol; 2002 Jun; 89(2):133-41. PubMed ID: 12120755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.
    Schoenfeld P
    Gastroenterol Clin North Am; 2005 Jun; 34(2):319-35, viii. PubMed ID: 15862938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
    Johanson JF
    Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium polycarbophil improves constipation in non-traumatic spinal cord disorders.
    Sakakibara R; Yamaguchi T; Uchiyama T; Liu Z; Yamamoto T; Ito T; Odaka T; Hattori T
    Clin Auton Res; 2006 Aug; 16(4):289-92. PubMed ID: 16810464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects.
    Sakakibara R; Yamaguchi T; Uchiyama T; Yamamoto T; Ito T; Liu Z; Odaka T; Yamaguchi C; Hattori T
    Mov Disord; 2007 Aug; 22(11):1672-3. PubMed ID: 17149723
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of calcium-polycarbophil in the treatment of non-specific diarrhea].
    Gizzi G; Villani V; Rubinetto MP; Cianci M; La Froscia A; Barbara L
    Minerva Gastroenterol Dietol; 1993 Sep; 39(3):139-43. PubMed ID: 8286486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Irritable bowel syndrome].
    Musch A
    Med Monatsschr Pharm; 2006 Oct; 29(10):378-9. PubMed ID: 17058897
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM; Raudibaugh K; Frissora CL; Kassem N; Keogh JC; Phillips J; Mangel AW
    Aliment Pharmacol Ther; 2008 Jan; 27(2):197-206. PubMed ID: 17973974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for irritable bowel syndrome.
    Treat Guidel Med Lett; 2006 Mar; 4(43):11-6. PubMed ID: 16498305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium polycarbophil in clinical practice. The therapy of constipation].
    Pallotta N; Rubinetto MP; Zaccaro C; Gizzi G; Villani V; Barbara L
    Minerva Gastroenterol Dietol; 1993 Dec; 39(4):175-8. PubMed ID: 8161616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology, toxicology, clinical efficacy, and adverse effects of calcium polycarbophil, an enteral hydrosorptive agent.
    Danhof IE
    Pharmacotherapy; 1982; 2(1):18-28. PubMed ID: 6765389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.
    Lacy BE
    Neurogastroenterol Motil; 2016 Jan; 28(1):26-35. PubMed ID: 26690872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of total costs of administering calcium polycarbophil and psyllium mucilloid in an institutional setting.
    Mamtani R; Cimino JA; Cooperman JM; Kugel R
    Clin Ther; 1990; 12(1):22-5. PubMed ID: 2109660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.